SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-08
👔
CORCEPT THERAPEUTICS INC
@CORT_InsiderForm 4 Filing: Guyer William Sells $2.3M of $CORT
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
CORCEPT THERAPEUTICS INC
Ticker: $CORT
Transaction Value
$2.3M
Price/Share: $57.39
transaction date
2026-07-07
Shares: 40,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Guyer William, holds the title of Chief Development Officer at CORCEPT THERAPEUTICS INC.
On 2026-07-07, the insider transacted 40,000 shares.The shares were transacted at a weighted average price of $57.39 per share, resulting in a total market-relevant value of $2.3M.
Executive Summary Summary
Guyer William (Chief Development Officer) sold $2.3M of $CORT
Post-Transaction Position: 4,937 shares
SEC Accession No: 0001193125-26-298865 (CIK: 1879013)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.